Here are the key takeaways from it:-
- Methyl Amine capacity is getting increased from 24,000 to 54,000 tons
- Production of dimethylformide is to start by end of 2013. Total capacity planned is 30,000 tons. Currently, only RCF manufactures this in India and has a capacity of 5,000 tons. India imports the rest of the demand of around 30,000 tons. After Balaji's capacity comes online, India may be in a position to meet all of its needs domestically with some export opportunities as well.
- The expected revenue from both these initiatives from a 3-year timeframe (2014-15) is about 350 cr. 180 cr is expected from the methyl amine expansion and another 170 cr from dimethylformide.
- The company has filed for European DMF for PVP K30. It will take about 6-8 months to get approval. Once approved, the company will be able to export PVP K30 to Europe.
- The interest costs have gone up dramatically from 9-10% to 13.5-14% currently. This has resulted in high interests costs this quarter and is likely to remain like this for the next few quarters.
- Prices of key raw materials have also increased after accidents in BASF and Nan Ya Plastics, two large global suppliers.
- The company has a capex plan of 70 cr out of which 50 cr is for the methyl amine expansion and 20 cr for setting up dimethyl formide production.
- Company has a working capital loan of about 80-85 cr and total loan book of 157 cr.
- The newly added capacities are working at 40-50% of capacity currently.
- The company is targeting a topline of 420-450 cr in FY12
- The company is targeting a PBT of 47-48 cr in FY12
- The promoter holds 54% of the company's stock and another 20% is held by close relatives. 20% of promoter holding is pledged to banks to get beneficial terms for the term loans.